Skip to main content
OpenTrials
Completed

NCT Number: NCT00930709

Botulinum Toxin Versus Active Strength Training in the Treatment of Lateral Epicondylitis

The purpose of this study is to compare efficacy, feasibility and cost effectiveness of botulinum toxin type A injections to active nine weeks strength training and stretching program in the treatment of the chronic lateral epicondylitis.

The main hypothesis is that the botulinum toxin type A injections may enable more rapid pain relief while strength training may provide better functional results and less relapses during the follow-up.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Physical medicine and Rehabilitation, Seinäjoki Central Hospital

Seinäjoki, 60220, Finland

About this study

INTRODUCTION:

Lateral epicondylitis (tennis elbow) is a frequent repetitive stress injury, affecting the common extensor muscles at the lateral humeral epicondyle. Lateral epicondylitis has a well-known spontaneous healing tendency. Still the prevalence of the chronic lateral epicondylitis is 1.4% in working populations causing significant occupational disability and financial burden.

Systematic reviews of the effectiveness of different treatment modalities for lateral epicondylitis present conflicting results. There are no consistent guidelines for management of the prolonged lateral epicondylitis. Progressive strengthening and stretching exercises as well as botulinum toxin type A injections have been suggested to be effective in treatment of chronic cases. However, there are only a few studies comparing different treatment modalities and botulinum toxin treatment have not been included in any of these.

The purpose of this study is to compare efficacy, feasibility and cost effectiveness of the botulinum toxin type A injections to active nine weeks strength training and stretching program in the treatment of the chronic lateral epicondylitis.

The main hypothesis is that the botulinum toxin type A injections may enable more rapid pain relief while strength training may provide better functional results and less relapses during the follow-up.

SUBJECTS AND METHODS:

A sample size of 120 participants with an equal drop-out rate of 15 % per group was determined in advance to detect a clinically significant 30 percentage points difference in outcome measures between the treatment groups with the minimum success rate of 65 % at the statistical significance level of 0.05 and power of 80 %.

During the recruitment process all patient newly referred to Department of PM&R outpatient clinics in the Seinäjoki Central Hospital due to elbow pain are evaluated by the study investigators. Every eligible patient with written informed consent is recruited. A computerised random number generator is used to draw up an allocation schedule. Patients are allocated in treatment groups via opaque sealed envelopes marked according to the random schedule.

Measurements and training instructions are performed by five trained physical therapists. In addition to detailed personal training instructions given by physical therapist, illustrated instructions as well as instruction video will be provided for patients in the training group. Physical therapists instructing patients do not perform any measurements to enable blinding of assessor. Measurement devices are calibrated regularly according to the manufacturers' recommendations and quality assurance measurements with test weights are performed on regular basis.

The principal statistical analysis will be done on an intention-to-treat basis. Repeated measures of ANCOVA and Cox Proportional Hazard Regression are planned to be used as primary methods. If there will be relapses, more advanced longitudinal models such as Generalised Estimating Equations and Random Coefficient Analysis will be used.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • pain at the lateral side of the elbow over 3 months
  • local tenderness on palpation over the lateral epicondyle
  • positive Mill's sign
  • lateral elbow pain progression on resisted wrist and/or middle finger extension
  • involved in working life

Exclusion criteria

  • bilateral symptoms or simultaneous medial epicondylitis
  • verified or suspected cervical radiculopathy or affected limb neuropathy
  • congenital or acquired deformities of the elbow
  • previous surgery of the elbow
  • infection, dislocation, tendon ruptures, or fractures in the area
  • systemic musculoskeletal or neurological disorders, incl. rheumatic diseases and fibromyalgia
  • allergy, antibodies or other contraindications for botulinum toxin
  • severe depression, chronic pain syndrome or somatisation disorder
  • ongoing retirement process
  • pregnancy or breastfeeding
  • current participation in other clinical trials

Treatment and study plan

Botulinum toxin type A (Botox®, Allergan)

Drug

Two injections of 10-60 units of botulinum toxin type A. Injections are administered with ENMG assisted technique at the baseline and after 13 weeks.

Other names: Botox®, Allergan, NDC 0023-1145-01

Active strength training and stretching

Behavioral

Training duration 9 weeks, intensified every 3 weeks in supervision of physiotherapist. Training program includes progressive, slow, repetitive wrist and forearm stretching, eccentric muscle strengthening, occupational exercises and upper limb neural mobilization training.

Other names: Eccentric strength training

Primary outcomes

  1. Pain, 100 mm visual analogue scale, change from baseline

    Time frame: 0, 6, 13, 26, 39, 52 weeks

  2. Grip strength (pain free and maximal), hydraulic hand dynamometer, change from baseline

    Time frame: 0, 6, 13, 26, 39, 52 weeks

Secondary outcomes

  1. Experienced disability, 100 mm visual analogue scale, change from baseline

    Time frame: 0, 6, 13, 26, 39, 52 weeks

  2. Isometric wrist extension and flexion strength, digital hanging scale with rigid bench frame, change from baseline

    Time frame: 0, 6, 13, 26, 39, 52 weeks

  3. Treatment adverse effects

    Time frame: 0, 6, 13, 26, 39, 52 weeks

  4. Economic evaluation of interventions, direct and indirect costs

    Time frame: 0, 6, 13, 26, 39, 52 weeks

  5. Days in sick leave

    Time frame: 0, 6, 13, 26, 39, 52 weeks

  6. Experienced forearm pain and disability, The Patient-Rated Tennis Elbow Evaluation (PRTEE)

    Time frame: 0, 6, 13, 26, 39, 52 weeks

  7. General improvement, 7-point Likert scale

    Time frame: 0, 6, 13, 26, 39, 52 weeks

Sponsors and collaborators

Lead sponsor

Seinajoki Central Hospital

Other

Registry information

Official study title

Botulinum Toxin Versus Active Strength Training in Treatment of the Lateral Epicondylitis - A Single-Blinded, Randomized, Controlled Trial

Acronym: BooST

Important dates

Study start
2009
Primary completion
2014
Study completion
2014
First posted
Jun 30, 2009
Registry last updated
Dec 31, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.